Summary
- Main use
- Improvement of encephalopathy due to chronic liver disease
- Who receives it
- Adults
- Adult administration
- ○ Adults: Generally, administer 500 mL per dose by intravenous infusion. ○ Infusion rate: Usually, administer 500 mL over at least 180 minutes in adults. ○ Administration via a central vein: Mix 500 mL of this drug with a carbohydrate-containing intravenous solution, etc., and continuously infuse into a central vein over 24 hours. Adjust the dose appropriately according to age, symptoms, and body weight.
Ingredients
- L-Isoleucine920mg / 100mL
- L-Leucine945mg / 100mL
- L-Lysine Acetate395mg / 100mL
- L-Methionine44mg / 100mL
- L-Phenylalanine30mg / 100mL
- L-Threonine214mg / 100mL
- L-Tryptophan70mg / 100mL
- L-Valine890mg / 100mL
- L-Alanine840mg / 100mL
- L-Arginine1537mg / 100mL
- L-Aspartic Acid20mg / 100mL
- L-Histidine310mg / 100mL
- L-Proline530mg / 100mL
- L-Serine260mg / 100mL
- L-Tyrosine40mg / 100mL
- Glycine540mg / 100mL
- Manufacturer
- Hanol BioPharma Co., Ltd.
Efficacy & effects
Improvement of encephalopathy due to chronic liver disease
- Encephalopathy due to chronic liver dysfunction
View approved original textHide original text
This medication is used for the improvement of symptoms of encephalopathy caused by chronic liver dysfunction.
How it is given
Adult administration
○ Adults: Generally, administer 500 mL per dose by intravenous infusion. ○ Infusion rate: Usually, administer 500 mL over at least 180 minutes in adults. ○ Administration via a central vein: Mix 500 mL of this drug with a carbohydrate-containing intravenous solution, etc., and continuously infuse into a central vein over 24 hours. Adjust the dose appropriately according to age, symptoms, and body weight.
Precautions
This medication must be used according to a doctor's instructions. Do not use in patients with severe renal impairment or high nitrogen levels in the blood, as well as patients with amino acid metabolism disorders beyond liver dysfunction. It should also not be administered to patients with metabolic disorders affecting nitrogen utilization, severe congestive heart failure, or fluid in the lungs. Do not use in patients with very little or no urine output, high sodium and chloride levels in the blood, cardiac conduction disturbances, or myasthenia gravis due to specific components of this medication. Patients who have been excessively supplied with fluids or have had a myocardial infarction, or had a history of myocardial infarction should also avoid this medication. Use with caution in patients with severe acidosis, congestive or severe heart failure, patients with edema due to sodium, patients with high potassium levels or potassium retention, and patients with impaired renal function. This medication contains sodium bisulfite, which may cause allergic reactions or asthma attacks in sensitive patients or asthmatics. Rarely, allergic reactions such as skin rashes may occur, and if such symptoms arise, usage should be discontinued immediately. Gastrointestinal symptoms like nausea or vomiting may occur occasionally, along with chest discomfort, palpitations, rapid heartbeat, or elevated blood pressure. Administering a large volume rapidly can lead to acidosis, so care must be taken. Additionally, symptoms such as chills, fever, headache, difficulty breathing, respiratory arrest, shock, bronchospasm, and urinary cramps may also appear. If magnesium is included, peripheral blood vessels may dilate, leading to decreased blood pressure. There is a risk for metabolic acidosis, hypophosphatemia, alkalosis, hyperglycemia, diabetes, dehydration, rebound hypoglycemia, elevated liver enzymes, vitamin deficiencies or excesses, electrolyte imbalances, and hyperammonemia in children. Patients with poor liver or kidney function may experience elevated blood urea nitrogen (BUN) levels, and those with severely compromised liver function may exhibit serious symptoms such as amino acid imbalance, metabolic alkalosis, systemic nitrogen blood syndrome, hyperammonemia, or coma. Care should be taken regarding electrolyte balance when co-administering with other medications containing electrolytes or during large doses. Overdose can lead to metabolic alkalosis, hence formulations containing acetate ions should be used with caution. In patients with renal disease, pulmonary disease, or severe heart disease, care must be taken to avoid excessive fluid retention. Diabetic patients must frequently monitor their blood glucose levels while using this medication. Patients with hyponatremia, liver failure, or kidney failure should have doses adjusted individually, and hydration balance and serum electrolyte levels must be carefully monitored. This medication may reduce protein synthesis effects when used with certain antibiotics, and if magnesium is included, co-administration with calcium injections may lead to precipitation, so caution is advised. Safety in pregnant women has not been established, so it should only be administered when the benefits outweigh the risks. Children may have immature liver function, so maintain lower dosages, and especially infants should have their blood ammonia levels monitored frequently. Elderly patients may have diminished physiological functions, thus administration rate should be slow and dosage reduced for cautious use. Since this medication contains electrolytes, care must be taken regarding electrolyte balance during high volume administration, and the administration rate should be slowed to prevent side effects like chills or vomiting. When administering, prepare the drug at body temperature and ensure aseptic conditions to reduce the risk of infections. Do not use if the solution is cloudy or discolored, and it should be used within 24 hours if refrigerated. During storage, do not open the packaging, and do not use if the rubber stopper is damaged.
Side effects
- Rash
- nausea
- vomiting
- chest discomfort
- palpitations
- tachycardia
- elevated blood pressure
- acidosis
- chills
- fever
Show 27 moreCollapse
- headache
- dyspnea
- respiratory arrest
- shock
- bronchial spasm
- ureteral spasm
- peripheral vasodilation
- metabolic acidosis
- hypophosphatemia
- alkalosis
- hyperglycemia
- diabetes mellitus
- osmotic diuresis
- dehydration
- rebound hypoglycemia
- elevated liver enzymes
- vitamin deficiency
- vitamin excess
- electrolyte imbalance
- pediatric hyperammonemia
- elevated BUN
- serum amino acid imbalance
- metabolic alkalosis
- systemic nitrogenemia
- hyperammonemia
- sensory loss
- coma
Not everyone experiences these, and they can vary from person to person.
Storage
This medication should be stored in a sealed container to avoid contact with air, kept away from direct sunlight, and stored at room temperature. Proper storage will help maintain the drug's effectiveness and prevent degradation.
Appearance and packaging
Appearance
A colorless to pale yellow transparent solution in a colorless transparent glass vial or in a polypropylene aqueous injection container.
Package unit
100mL/bottle, 200mL/bottle, 250mL/bottle, 500mL/bottle
Questions about this medicine
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.